Where the Deal Flow Is

HLTH USA 2026 is where healthcare’s most active investors source companies, meet founders, and take the pulse of an industry mid-transformation. With 1,675+ startups, 1,405+ investors, and 1,645+ curated 1:1 meetings at HLTH USA 2025, it’s the most concentrated gathering of healthcare deal flow in the country.

Why Investors Attend

For curated deal flow via Investor Connect.

Investor Connect is HLTH USA's dedicated matchmaking program pairing leading VCs and investors with healthcare technology startup CEOs and founders in 15-minute 1:1 meetings. 

To evaluate early-stage companies at the Startup Pitch Competitions.

Four competitions: the HLTH USA Pitch, Women's Health, Health Equity, and AgeTech Collaborative from AARP challenges, put the most promising startups on stage. It's a great way to see some early-stage companies across the categories attracting the most capital right now.

To scout deal flow at the Startup Zone.

The Startup Zone is HLTH USA's dedicated destination for early-stage companies featuring Club Startup kiosks on the show floor, Startup Theater sessions on building and scaling, and the Investor Connect Lounge, where deals start and relationships form. 

To understand what buyers actually want.

HLTH USA puts investors in the same room as the health system CMOs, payer executives, and employer benefits leaders whose adoption decisions determine whether portfolio companies succeed. Understanding the buyer's perspective is one of the most valuable things to bring back to due diligence

Who You Can Expect Onsite

Reset

Loading...

Past Sessions

Mad Healthcare Money: Investor Hot Takes

Digital health funding has sobered up significantly since the 2020–2021 bubble, and investors who survived the correction are now placing calculated bets on sectors and business models they believe will define healthcare's next chapter. Tighter due diligence has replaced pandemic-era euphoria and sustainable unit economics actually matter now. Featuring speakers from NEA, Emerson Collective, and Northzone, moderated by Axios. Watch Now.

The Biotech Builders

Biotech unicorns represent a rare breed, companies that somehow hit billion-dollar valuations while navigating an industry where nine out of ten drugs fail and one FDA rejection can set back years of work. This Founder Tell-All session examined how they cracked the code at the intersection of cutting-edge science and brutal commercial realities. Featuring speakers from Absci and Mammoth Biosciences, moderated by Flagship Pioneering. Watch Now.

Built to Last Startups

Healthcare founders face a reality different from any other industry. Valuation isn't everything, and survival matters more than inflated metrics. This session tackled the decisions that define healthcare companies: when to dilute equity, how to hire scarce specialized talent, and how to build the agility to pivot when clinical setbacks or market dynamics demand it. Featuring speakers from General Catalyst, Mount Sinai Ventures, and Scrub Capital, moderated by American Heart Association Ventures. Watch Now.

VIEW MORE SESSIONS

Hear From Past Attendees

"HTLH has been instrumental in helping us at Samsung Next build both our investor network as well as access and make multiple investments over the years. The ROI on our marketing investments in HLTH is unquestionable."
Managing DirectorSamsung NEXT Ventures
"Every conference has it's own signature energy and HLTH's is pure CEO energy everywhere."
Senior AI Strategy ConsultantDeloitte
"HLTH shows that progress in healthcare comes from partnership, across payers, care providers, manufacturers and innovators of all kinds. I’m leaving inspired by the possibilities ahead."
Executive Vice President, Chief Information OfficerJohnson & Johnson

Your Next Step

Learn more about HLTH USA and be at the forefront of innovation. Empower yourself with the knowledge and connections to identifying groundbreaking investment opportunities.

REGISTER & JOIN US
BECOME A SPONSOR

Filter Sessions